Aquablation therapy is the first and only ultrasound-guided, robotic-assisted, heat-free waterjet treatment for BPH, setting a new standard in care. This advanced procedure combines precision and personalization, using real-time ultrasound guidance to tailor the treatment to each patient’s unique prostate anatomy. It delivers long-lasting symptom relief while preserving sexual function and continence, offering patients a revolutionary approach to BPH management.
Performed by Dr. Steven Sterious, a Fox Chase-Temple urologist who was directly involved in the research and development of this transformative technology, patients can get back to life with little to no longstanding issues.
Aquablation therapy is the first and only ultrasound-guided, robotic-assisted, heat-free waterjet treatment for BPH, setting a new standard in care. This advanced procedure combines precision and personalization, using real-time ultrasound guidance to tailor the treatment to each patient’s unique prostate anatomy. It delivers long-lasting symptom relief while preserving sexual function and continence, offering patients a revolutionary approach to BPH management.
Performed by Dr. Steven Sterious, a Fox Chase-Temple urologist who was directly involved in the research and development of this transformative technology, patients can get back to life with little to no longstanding issues.
Studies on aquablation for BPH indicate that it is an effective treatment, offering significant symptom relief with a lower risk of sexual side effects compared to traditional surgical methods. However, findings suggest that patient outcomes may vary based on prostate size and surgeon experience, highlighting the need for individualized treatment considerations.
Aquablation® therapy utilizes a cutting-edge platform that delivers precise and efficient prostate tissue removal. This advanced system combines:
Appointments are available for any patient interested in finding a treatment for benign prostatic hyperplasia.
To refer a patient, contact our Key Account Manager, Jennifer Enoch:
Aquablation® therapy offers a revolutionary approach to treating Benign Prostatic Hyperplasia (BPH), providing numerous benefits that prioritize both effectiveness and patient quality of life.
With a focus on precision, safety, and clinical outcomes, Aquablation therapy sets a new standard in BPH care, helping your patients achieve lasting symptom relief and improved quality of life.
We welcome the opportunity to collaborate with you to offer this state-of-the-art treatment to your patients. If you want more information, patient brochures, or to discuss Aquablation therapy in detail, please contact:
Disclaimer: Temple University Health System (TUHS) neither provides nor controls the provision of health care. All health care is provided by its member organizations or independent health care providers affiliated with TUHS member organizations. Each TUHS member organization is owned and operated pursuant to its governing documents. Temple Health refers to the health, education and research activities carried out by the affiliates of Temple University Health System and by the Lewis Katz School of Medicine.
